Sources and dynamics of fluorescent particles in hospitals

Indoor Air

Volumn 27, Issue 5, 2017, Pages 988-1000

  Pereira, M L ^a,b   Knibbs, L D ^a,c   He, C ^a   Grzybowski, P ^a,d   Johnson, G R ^a   Huffman, J A ^e   Bell, S C ^f,g   Wainwright, C E ^c,h   Matte, D L ⁱ   Dominski, F H ⁱ   Andrade, A ⁱ   Morawska, L ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Science and Technology of Santa Catarina   (Brazil)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^e UNIVERSITY OF DENVER   (United States)

^f THE PRINCE CHARLES HOSPITAL   (Australia)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^h LADY CILENTO CHILDREN S HOSPITAL   (Australia)

ⁱ SANTA CATARINA STATE UNIVERSITY   (Brazil)

Author keywords

application of UVAPS; fluorescent airborne particles; indoor air in hospitals; particle concentration and size distribution; real time bioaerosol detection; sources to indoor aerosol

Indexed keywords

AEROSOLS; FLUORESCENCE;

AIRBORNE PARTICLE; APPLICATION OF ULTRAVIOLET AERODYNAMIC PARTICLE SIZER; BIO-AEROSOL DETECTIONS; FLUORESCENT AIRBORNE PARTICLE; INDOOR AEROSOLS; INDOOR AIR; INDOOR AIR IN HOSPITAL; PARTICLE CONCENTRATION DISTRIBUTION; PARTICLES-SIZE DISTRIBUTIONS; REAL- TIME; REAL-TIME BIOAEROSOL DETECTION; SOURCE TO INDOOR AEROSOL; ULTRAVIOLET AERODYNAMIC PARTICLE SIZERS;

HOSPITALS;

AEROSOL; ANALYSIS; AUSTRALIA; CLASSIFICATION; CLINICAL TRIAL; CROSS INFECTION; ENVIRONMENTAL MONITORING; FLUORESCENCE; HOSPITAL; INDOOR AIR POLLUTION; MICROBIOLOGY; MULTICENTER STUDY; TIME FACTOR; TRANSMISSION;

AEROSOLS; AIR MICROBIOLOGY; AIR POLLUTION, INDOOR; AUSTRALIA; CROSS INFECTION; ENVIRONMENTAL MONITORING; FLUORESCENCE; HOSPITALS; TIME FACTORS;

EID: 85018792516     PISSN: 09056947     EISSN: 16000668     Source Type: Journal    
DOI: 10.1111/ina.12380     Document Type: Article

References (66)

1. Fernstrom A, Goldblatt M. Aerobiology and its role in the transmission of infectious diseases. J Pathog. 2013;2013:493960. https://doi.org/10.1155/2013/493960.
2. Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air. 2006;16:335-347.
3. Davane M, Suryawanshi N, Pichare A, Nagoba B. Pseudomonas aeruginosa from hospital environment. J Microbiol Infect Dis. 2014;4:42-43.
4. Pereira ML, Vilain R, Galvão FHF, Tribess A, Morawska L. Experimental and numerical analysis of the relationship between indoor and outdoor airborne particles in an operating room. Indoor Built Environ. 2013;22:864-875.
5. Andersen BM, Roed RT, Solheim N, et al. Air quality and microbiologic contamination in operating theatres. Tidsskr Nor Laegeforen. 1998;118:3148-3151.
6. Creamer E, Humphreys H. The contribution of beds to healthcare-associated infection: the importance of adequate decontamination. J Hosp Infect. 2008;69:8-23.
7. Dai C, Zhang Y, Ma X, et al. Real-time measurements of airborne biologic particles using fluorescent particle counter to evaluate microbial contamination: results of a comparative study in an operating theater. Am J Infect Control. 2015;43:78-81.
8. Greene VW, Vesley D, Bond RG, Michlaelsen MS. Microbiological studies of hospital air. II. Quantitative studies. Appl Microbiol. 1962;10:567-671.
9. Goodley JM, Clayton YM, Hay RJ. Environmental sampling for aspergilli during building construction on a hospital site. J Hosp Infect. 1994;26:27-35.
10. Jung CC, Wu PC, Tseng CH, Su HJ. Indoor air quality varies with ventilation types and working areas in hospitals. Build Environ. 2015;85:190-195.
11. Knibbs LD, Morawska L, Bell SC, Grzybowski P. Room ventilation and the risk of airborne infection transmission in 3 health care settings within a large teaching hospital. Am J Infect Control. 2011;39:866-872.
12. Lavoie J, Marchand G, Cloutier Y, et al. Evaluation of bioaerosol exposures during hospital bronchoscopy examinations in Airmon 2014: international Symposium on Modern Principles of Air Monitoring and Biomonitoring, (8th: June 15-19, 2014: Marseille, France). Environ Sci Process Impacts. 2015;17:288-299.
13. Morawska L, Jamriska M, Francis P. Particulate matter in the hospital environment. Indoor Air. 1998;8:285-294.
14. Pastuszka JS, Marchwiñska-Wyrwa E, Wlaz A. Bacterial Aerosol in Silesian Hospitals: preliminary results. Pol J Environ Stud. 2005;14:883-890.
15. Roberts K, Hathway EA, Fletcher LA, Beggs CB, Elliot MW, Sleigh PA. Bioaerosol production on a respiratory ward. Indoor Built Environ. 2006;15:35-40.
16. Sexton T, Clarke P, O'Neill E, Dillane T, Humphreys H. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect. 2006;62:87-194.
17. Shiomori T, Miyamoto H, Makishima K, et al. Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect. 2002;50:30-35.
18. Wang X, Bi X, Chen D, Sheng G, Fu J. Hospital indoor respirable particles and carbonaceous composition. Build Environ. 2006;41:992-1000.
19. Després VR, Huffman JA, Burrows SM, et al. Primary biological aerosol particles in the atmosphere: a review. Tellus B Chem Phys Meteorol. 2012;64:15598.
20. Douwes J, Thorne P, Pearce N, Heederik D. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47:187-200.
21. Beggs C, Knibbs LD, Johnson GR, Morawska L. Environmental contamination and hospital-acquired infection: factors that are easily overlooked. Indoor Air. 2015;25:462-474.
22. Bhangar S, Adams RI, Pasut W, et al. Chamber bioaerosol study: human emissions of size-resolved fluorescent biological aerosol particles. Indoor Air. 2016;26:193-206.
23. Bhangar S, Huffman JA, Nazaroff WW. Size-resolved fluorescent biological aerosol particle concentrations and occupant emissions in a university classroom. Indoor Air. 2014;24:604-617.
24. Handorean A, Robertson CE, Harris JK, et al. Microbial aerosol liberation from soiled textiles isolated during routine residuals handling in a modern health care setting. Microbiome. 2015;3:1-10.
25. Agranovski V, Ristovski Z, Hargreaves M, Blackall PJ, Morawska L. Real-time measurement of bacterial aerosols with the UVAPS: performance evaluation. J Aerosol Sci. 2003b;34:301-317.
26. Kanaani H, Hargreaves M, Ristovski ZD, Morawska L. Deposition rates of fungal spores in indoor environments, factors effecting them and comparison with non-biological aerosols. Atmos Environ. 2008;42:7141-7154.
27. Huffman JA, Treutlein B, Pöschl U. Fluorescent biological aerosol particle concentrations and size distributions measured with an Ultraviolet Aerodynamic Particle Sizer (UV-APS) in Central Europe. Atmos Chem Phys. 2010;10:3215-3233.
28. Brosseau LM, Vesley D, Rice N, Goodell MN, Hairston P. Differences in detected fluorescence among several bacterial species measured with a direct-reading particle sizer and fluorescence detector. Aerosol Sci Technol. 2000;32:545-558.
29. Hairston PP, Ho J, Quant FR. Design of an instrument for real-time detection of bioaerosols using simultaneous measurement of particle aerodynamic size and intrinsic fluorescence. J Aerosol Sci. 1997;28:471-482.
30. Agranovski V, Ristovski Z, Hargreaves M, Blackall PJ, Morawska L. Performance evaluation of the UVAPS: influence of physiological age of airborne bacteria and bacterial stress. J Aerosol Sci. 2003a;34:1711-1727.
31. Ho J. Future of biological aerosol detection. Anal Chim Acta. 2002;457:125-148.
32. Huffman JA, Santarpia JL. Chapter 4: online techniques for quantification and characterization of biological aerosol. In: Delort AM, Amato P, eds. Microbiology of Aerosols. Hoboken, NJ: Wiley; 2017.
33. Pöhlker C, Huffman JA, Pöschl U. Autofluorescence of atmospheric bioaerosols – fluorescent biomolecules and potential interferences. Atmos Meas Tech. 2012;5:37-71.
34. Morawska L, Pereira L, He C. Indoor Air Quality Assessment at the Royal Children's Hospital. Prepared for the Royal Children's Hospital, February; 2008.
35. Sivaprakasam V, Huston AL, Scotto C, Eversole JD. Multiple UV wavelength excitation and fluorescence of bioaerosols. Opt Express. 2004;12:4457-4466.
36. Agranovski V, Ristovski Z, Blackall PJ, Morawska L. Size-selective assessment of airborne particles in swine confinement building with the UVAPS. Atmos Environ. 2004;38:3893-3901.
37. Huffman JA, Prenni AJ, DeMott PJ, et al. High concentrations of biological aerosol particles and ice nuclei during and after rain. Atmos Chem Phys. 2013;13:6151-6164.
38. World Health Organization (WHO). Prevention of Hospital-Acquired Infections: A Practical Guide. Geneva, Switzerland: WHO/CDS/CSR/EPH/2002.12. 2002; 2002.
39. Bollin GE, Plouffe JF, Para MF, Hackman B. Aerosols containing Legionella pneumophila generated by shower heads and hot-water faucets. Appl Environ Microbiol. 1985;50:1128-1131.
40. EPA. Legionella Drinking Water Criteria Document. Washington, DC: United States Environmental Protection Agency, Office of Water; 1998.
41. Kowalski W. Hospital Airborne Infection Control. Boca Raton: CRC Press; 2012.
42. Vickers RM, Yu VL, Hanna SS, et al. Determinants of Legionella pneumophila contamination of water distribution systems: 15-hospital prospective study. Infect Control. 1991;8:357-363.
43. Tian Y, Licina D, Savage N, Huffman JA, Nazaroff WW. Size-resolved total particle and fluorescent biological aerosol particle emissions from clothing. Abstract #656. Conference: Indoor Air 2016, Ghent, Belgium, July 3-8; 2016.
44. Sanderson PJ, Weissler S. Recovery of coliforms from the hands of nurses and patients: activities leading to contamination. J Hosp Infect. 1992;21:85-93.
45. Tang JW, Li Y, Eames I, Chan PKS, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect. 2006;64:100-114.
46. Favero MS, Puleo JR, Marshall JH, Oxborrow GS. Comparison of microbial contamination levels among hospital operating rooms and industrial clean rooms. Appl Microbiol. 1968;16:480.
47. Hospodsky D, Qian J, Nazarof WW, et al. Human occupancy as a source of indoor airborne bacteria. PLoS One. 2012;7:e34867.
48. Flannigan B. Guidelines for evaluation of airborne microbial contamination in buildings. In: Johanning E, Yang Ch, eds. Proceedings of International Conference “Fungi and Bacteria in Indoor Air Environments. Health Effects, Detection and Remediation”. Saratoga Springs, NY: Eastern New York Occupational Health Program; 1994:123-129.
49. Nevalainen A. Bacterial Aerosols in Indoor Air. Kuopio: National Public Health Institute; 1989.
50. Khilnani GC, Banga A. Aerosol therapy. Indian J Chest Dis Allied Sci. 2008;50:209-219.
51. Kuhn RJ. Pharmaceutical considerations in aerosol drug delivery. Pharmacotherapy. 2002;22(3 Pt 2):80S-85S.
52. Anderson RL, Mackel DC, Stoler BS, Mallison GF. Carpeting in hospitals: an epidemiological evaluation. J Clin Microbiol. 1982;15:408-415.
53. Kemper RA, Ayers L, Jacobson C, Smith C, White WC (2005) Improved Control of Microbial Exposure Hazards in Hospitals: A 30-Month Field Study.
54. Mitchell JM. Impact on carpet tile in a hospital patient unit corridor: an observational case study, Thesis of master of interior design. University of Florida; 2006.
55. CDC. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52: 12, 13, 113, 124.
56. NDSC. National Guidelines for the Prevention of Nosocomial Invasive Aspergillosis During Construction/Renovation Activities. National Disease Surveillance Centre; 2002. ISBN 0-9540177-3-0
57. Grossman ME, Fithian EC, Behrens C, Bissinger J, Fracaro M, Neu HC. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol. 1985;12:313-318.
58. CRI. Carpet Maintenance Guidelines for Commercial Applications. Dalton, GA: The Carpet and Rug Institute; 2004.
59. Clark RP, Reed PJ, Seal DV, Stephenson ML. Ventilation conditions and air-borne bacteria and particles in operating theatres: proposed safe economies. J Hyg (Lond). 1985;95:325-335.
60. Veillette M, Knibbs LD, Pelletier A, et al. Microbial contents of vacuum cleaner bag dust and emitted bioaerosols and their implications for human exposure indoors. Appl Environ Microbiol. 2013;79:6331-6336.
61. Bate JG, James U. Salmonella typhimurium infection dust-borne in a children's ward. Lancet. 1958;2:713-715.
62. Haddock RL, Nocon FA. Infant salmonellosis and vacuum cleaners. J Trop Pediatr. 1994;40:53-54.
63. Nevas M, Lindstrom M, Virtanen A, et al. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol. 2005;43:511-513.
64. Hambraeus A, Bengtsson S, Laureli G. Bacterial contamination in a modern operating room. 3. Importance of floor contamination as a source of airborne bacteria. J Hyg (Lond). 1978;80:169.
65. Schumacher CJ, Pöhlker C, Aalto P, et al. Seasonal cycles of fluorescent biological aerosol particles in boreal and semi-arid forests of Finland and Colorado. Atmos Chem Phys. 2013;13:11987-12001.
66. ASHRAE. Standard 52.2-2012. Method of Testing General Ventilation Air-Cleaning Devices for Removal Efficiency by Particle Size. Atlanta: American Society of Heating, Refrigerating and Air-Conditioning Engineers, 2012.